Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00251524
Status:
COMPLETED
Last Update Posted:
2012-05-11
First Post:
2005-11-08
Brief Title:
A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC
Sponsor:
Veeda Oncology
Organization:
Veeda Oncology
Organization Data
Organization:
Veeda Oncology
Class:
OTHER
Study ID:
I-04-015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Veeda Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |
| Sanofi | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |